This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,948.02, is for the delivery of VYVANSE 10 MG CAPSULE 100S, a prescription medication used for the treatment of attention deficit hyperactivity disorder (ADHD). The contract has an ultimate completion date of October 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.
Generated 1/15/25, 9:29 AM